Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus

Author： Mitchell Beth D.   Eby Elizabeth L.   Lage Maureen J.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.29, Iss.12, 2013-12, pp. : 1587-1597

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of sliding scale insulin use on glycemic control and length of stay in hospitalized patients with Type 2 diabetes mellitus

By McFarlane Samy I   El-Atat Fadi   Castro Jonathan   Shin John   Joseph Linda   Bahtiyar Gul   Aneja Ashish   Bubb Chard   Muniyappa Ranganath   Kumar Pawan   Mellish Reba Williams Dawn A   Salifu Moro  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 81-85

Future Medicine

Access to resources Recommend Favorite

Oral antidiabetic agents in type 2 diabetes

By Levetan Claresa  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 945-952

Informa Healthcare

Access to resources Recommend Favorite

Oral antidiabetic drug therapy in type 2 diabetes mellitus - focus on elderly patients

By Lechleitner Monika  

Wiener Medizinische Wochenschrift, Vol. 161, Iss. 11-12, 2011-06 ,pp. : 297-299

Springer Publishing Company

Access to resources Recommend Favorite

Impact of rosiglitazone therapy on the lipid profile, glycemic control, and medication costs among type 2 diabetes patients

By Suh Dong-Churl   Lee Dong-Hyun   McGuire Michael   Kim Chul-Min  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1623-1633

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin add‐on to SU in China

By  

JOURNAL OF DIABETES, Vol. 7, Iss. 2, 2015-03 ,pp. : 174-181

John Wiley & Sons Inc

Access to resources Recommend Favorite